BRIEF published on 11/06/2024 at 07:50, 15 days 4 hours ago O'KEY Group Reveals Q3 2024 Operating Results O'KEY Group DA! Discounters Retail Revenue Q3 2024 Results Russia Food Retailer
PRESS RELEASE published on 11/06/2024 at 07:45, 15 days 4 hours ago O`KEY GROUP REPORTS OPERATING RESULTS FOR Q3 2024 O'KEY Group S.A. reports 4.4% YoY increase in net retail revenue for Q3 2024, driven by growth in O'KEY hypermarkets and DA! discounters. Full results on www.okeygroup.lu O'KEY Group S.A. Q3 2024 Net Retail Revenue DA! Discounters O'KEY Hypermarkets
BRIEF published on 08/23/2024 at 08:35, 2 months 29 days ago O'KEY Group Announces 35.4% EBITDA Growth for H1 2024 Profitability EBITDA Growth DA! Discounters Retail Revenue O’KEY Hypermarkets
PRESS RELEASE published on 08/23/2024 at 08:30, 2 months 29 days ago O`KEY GROUP REPORTS 35.4% EBITDA GROWTH FOR THE FIRST HALF OF 2024 O'KEY Group S.A. reports 35.4% EBITDA growth in H1 2024, driven by revenue increase and margin expansion. Financial results show improved profitability in retail and discount segments Revenue Increase Profitability EBITDA Growth O'KEY Group H1 2024
BRIEF published on 07/31/2024 at 08:50, 3 months 21 days ago O'KEY Group Reports 5.2% Retail Revenue Growth in Q2 2024 Q2 2024 O'KEY Group DA! Discounters Retail Revenue Net Growth
PRESS RELEASE published on 07/31/2024 at 08:45, 3 months 21 days ago O`KEY GROUP REPORTS 5.2% NET RETAIL REVENUE GROWTH IN Q2 2024 O'KEY Group S.A. reports 5.2% net retail revenue growth in Q2 2024. O'KEY hypermarkets' revenue up 1.0%, DA! discounters' revenue increased by 13.8% YoY Q2 2024 O'KEY Group Net Retail Revenue Hypermarkets Discounters
BRIEF published on 06/10/2024 at 18:05, 5 months 10 days ago O'KEY Group Transfers Its GDRs to II Level List on MOEX Stock Market O'KEY Group GDR Moscow Exchange Level II Quotation List
PRESS RELEASE published on 06/10/2024 at 18:00, 5 months 10 days ago O`KEY GROUP TRANSFERS ITS GDRs TO II LEVEL LIST ON MOEX O'KEY Group S.A. transfers its GDRs to II level list on MOEX. The Moscow Exchange moves the Company's GDRs to Level II Quotation List from 13 June 2024 O'KEY Group S.A. GDRs MOEX Moscow Exchange Level II List
BRIEF published on 05/21/2024 at 16:05, 5 months 30 days ago O'KEY Group AGM 2024 Results Shareholders Financial Statements Compensation AGM 2024 O'KEY Group
PRESS RELEASE published on 05/21/2024 at 16:00, 5 months 30 days ago O’KEY GROUP AGM 2024 Results O'KEY Group S.A. confirms adoption of all resolutions at the AGM 2024. Details of approved financial statements and compensation discussed Board Of Directors Financial Statements Compensation O'KEY Group S.A. AGM 2024
Published on 11/21/2024 at 12:00, 31 minutes ago Alset AI Announces Full Repayment of $3.7 Million Secured Loan with Interest from Portfolio Company, Significantly Strengthening Balance Sheet
Published on 11/21/2024 at 12:00, 31 minutes ago Battery X Metals Commences Strategic Initiatives to Strengthen Balance Sheet
Published on 11/21/2024 at 11:30, 1 hour 1 minute ago FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 2 hours 28 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 2 hours 31 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 12:15, 16 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 1 minute ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:00, 1 hour 31 minutes ago First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Published on 11/21/2024 at 06:58, 5 hours 33 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 17 hours 11 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 18 hours 46 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 18 hours 46 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 4 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
